Clinical trial
Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy…
NCT00199225 · J. Uriach and Company, Industry · Completed
Key facts
| NCT number | NCT00199225 |
|---|---|
| Title | Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers |
| Official title | Evaluation of Possible Effects on the QT/ QTc Interval of Rupatadine in Healthy Volunteers: A Randomised, Parallel, Placebo and Positive Controlled Study |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Human Experimentation (Human Volunteers) |
| Intervention type | Drug, Procedure |
| Interventions | Rupatadine, moxifloxacin, Continous electrocardiographic register, Pharmacokinetic profile |
| Enrollment | 160 |
| Start date | Feb 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 15, 2005 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: